✦ LIBER ✦

Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol

✍ Scribed by A Riccardi; O Mora; C Tinelli; C Porta; M Danova; S Brugnatelli; D Grasso; B Tolcà; R Spanedda; A De Paoli; L Barbarano; L Cavanna; M Giordano; C Delfini; G Nicoletti; C Bergonzi; E Rinaldi; L Piccinini; E Ascari

Book ID: 117659167
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 190 KB
Volume: 39
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(02)00529-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

778 Patients with multiple myeloma (MM)

778 Patients with multiple myeloma (MM) requiring long-term hemodialysis (HD): Presenting features, response to therapy and survival in a series of 20 patients

✍ J. Bladé; R. Torra; A. Cases; J. López-Pedret; E. Montserrat; L.I. Revert; C. Ro 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Progression-Free Survival in Children Wi

Progression-Free Survival in Children With Optic Pathway Tumors: Dependence on Age and the Quality of the Response to Chemotherapy--Results of the First French Prospective Study for the French Society of Pediatric Oncology

✍ Laithier, V. 📂 Article 📅 2003 🏛 American Society of Clinical Oncology 🌐 English ⚖ 270 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB